Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,482 | 5,742 | 16,903 | 13,987 | 25,176 |
| Marketable Securities | N/A | 7,970 | 5,420 | N/A | 17,466 |
| Receivables | 1,253 | 1,913 | N/A | 8,875 | 1,482 |
| Inventories | N/A | N/A | N/A | N/A | 10,655 |
| Other current assets | 2,477 | 2,807 | 2,449 | 4,320 | 10,115 |
| TOTAL | $12,212 | $18,432 | $24,772 | $27,182 | $64,894 |
| Non-Current Assets | |||||
| PPE Net | 73 | 147 | 176 | 285 | 1,294 |
| Other Non-Current Assets | 7,950 | 11,588 | 11,954 | 34,571 | 42,910 |
| TOTAL | $8,023 | $11,735 | $12,130 | $34,856 | $44,204 |
| Total Assets | $20,235 | $30,167 | $36,902 | $62,038 | $109,098 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 127 | 318 | 1,762 | 1,384 | 4,367 |
| Accrued Expenses | 1,271 | 2,067 | 2,552 | 4,599 | 6,589 |
| Other current liabilities | 12,726 | 14,319 | 7,671 | 24,143 | 20,542 |
| TOTAL | $14,922 | $18,057 | $14,563 | $47,892 | $134,574 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 716 | 1,011 | 1,607 | 15,983 | 95,092 |
| Other Non-Current Liabilities | 43,815 | 48,744 | 57,380 | 69,218 | 71,807 |
| TOTAL | $43,815 | $48,744 | $57,380 | $69,218 | $71,807 |
| Total Liabilities | $58,737 | $66,801 | $71,943 | $117,110 | $206,381 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,178 | 7,210 | 7,023 | 5,961 | 5,859 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -2,021,865 | -2,018,459 | -2,014,156 | -2,016,543 | -2,054,553 |
| Other shareholders' equity | 1 | 2 | 0 | 0 | 8 |
| TOTAL | $-38,502 | $-36,634 | $-35,041 | $-55,072 | $-97,283 |
| Total Liabilities And Equity | $20,235 | $30,167 | $36,902 | $62,038 | $109,098 |